Liquid biopsy challenge and hope in colorectal cancer

References

• Khakoo S, Georgiou A, Gerlinger M, et al. Circulating tumour DNA, a promising biomarker for the management of colorectal cancer. Crit Rev Oncol Hematol. 2018;122:72–82.
   PubMed Web of Science ®Google Scholar
• Tauriello DVF, Calon A, Lonardo E, et al. Determinants of metastatic competency in colorectal cancer. Mol Oncol. 2017;11(1):97–119.
   PubMed Web of Science ®Google Scholar
• Das V, Kalita J, Pal M. Predictive and prognostic biomarkers in colorectal cancer: A systematic review of recent advances and challenges. Biomed Pharmacother. 2017;87:8–19.
   PubMed Web of Science ®Google Scholar
• Garborg K, Holme O, Loberg M, et al. Current status of screening for colorectal cancer. Ann Oncol. 2013;24(8):1963–1972.
   PubMed Web of Science ®Google Scholar
• Bretthauer M. Colorectal cancer screening. J Intern Med. 2011;270(2):87–98.
   PubMed Web of Science ®Google Scholar
• Burz C, Pop V-V, Buiga R, et al. Circulating tumor cells in clinical research and monitoring patients with colorectal cancer. Oncotarget. 2018;9(36):24561–24571.
   PubMedGoogle Scholar
• Crowley E, Di Nicolantonio F, Loupakis F, et al. Liquid biopsy: monitoring cancer- genetics in the blood. Nat Rev Clin Oncol. 2013;10(8):472–484.
   PubMed Web of Science ®Google Scholar
• Alix-Panabieres C, Pantel K. Clinical Applications of Circulating Tumor Cells and Circulating Tumor DNA as Liquid Biopsy. Cancer Discov. 2016;6(5):479–491.
   PubMed Web of Science ®Google Scholar
• Gazzaniga P, Raimondi C, Nicolazzo C, et al. The rationale for liquid biopsy in colorectal cancer: a focus on circulating tumor cells. Expert Rev Mol Diagn. 2015;15(7):925–932.
   PubMed Web of Science ®Google Scholar
• Yap TA, Lorente D, Omlin A, et al. Circulating Tumor Cells: A Multifunctional Biomarker. Clin Cancer Res. 2014;20(10):2553–2568.
   PubMed Web of Science ®Google Scholar
• Augestad KM, Merok MA, Ignatovic D. Tailored Treatment of Colorectal Cancer: Surgical, Molecular, and Genetic Considerations. Clin Med Insights Oncol. 2017;11:117955491769076.
   Web of Science ®Google Scholar
• Lu Y, Yu T, Liang H, et al. Nitric Oxide Inhibits Hetero-adhesion of Cancer Cells to Endothelial Cells: Restraining Circulating Tumor Cells from Initiating Metastatic Cascade. Sci Rep. 2014;4:4344.
   PubMed Web of Science ®Google Scholar
• Maheswaran S, Haber DA. Circulating tumor cells: a window into cancer biology and metastasis. Curr Opin Genet Dev. 2010;20(1):96–99.
   PubMed Web of Science ®Google Scholar
• Plaks V, Koopman CD, Werb Z. Circulating Tumor Cells. Science. 2013;341(6151):1186–1188.
   PubMed Web of Science ®Google Scholar
• Mitra A, Mishra L, Li S. EMT, CTCs and CSCs in tumor relapse and drug-resistance. Oncotarget. 2015;6(13):10697–10711.
   PubMed Web of Science ®Google Scholar
• Garg M. Targeting microRNAs in epithelial-to-mesenchymal transition-induced cancer stem cells: therapeutic approaches in cancer. Expert Opin Ther Targets. 2015;19(2):285–297.
   PubMed Web of Science ®Google Scholar
• Sosa MS, Bragado P, Aguirre-Ghiso JA. Mechanisms of disseminated cancer cell dormancy: an awakening field. Nat Rev Cancer. 2014;14(9):611–622.
   PubMed Web of Science ®Google Scholar
• Steinert G, Schölch S, Niemietz T, et al. Immune Escape and Survival Mechanisms in Circulating Tumor Cells of Colorectal Cancer. Cancer Res. 2014;74(6):1694–1704.
   PubMed Web of Science ®Google Scholar
• Amo L, Tamayo-Orbegozo Eb, Maruri N, et al. Involvement of Platelet–Tumor Cell Interaction in Immune Evasion. Potential Role of Podocalyxin-Like Protein 1. Front Oncol. 2014;4:245.
   Google Scholar
• Ammendola M, Patruno R, Sacco R, et al. Mast cells positive to tryptase and tumour- associated macrophages correlate with angiogenesis in locally advanced colorectal cancer patients undergone to surgery. Expert Opin Ther Targets. 2016;20(5):533–540.
   PubMed Web of Science ®Google Scholar
• Paschos KA. Natural history of hepatic metastases from colorectal cancer - pathobiological pathways with clinical significance. World J Gastroenterol. 2014;20(14):3719–3737.
   PubMed Web of Science ®Google Scholar
• Ceausu AR, Ciolofan A, Cimpean AM, et al. The Mesenchymal-Epithelial and Epithelial-Mesenchymal Cellular Plasticity of Liver Metastases with Digestive Origin. Anticancer Res. 2018;38(2):811–816.
   PubMed Web of Science ®Google Scholar
• Burrell RA, McGranahan N, Bartek J, et al. The causes and consequences of genetic heterogeneity in cancer evolution. Nature. 2013;501(7467):338–345.
   PubMed Web of Science ®Google Scholar
• Jia S, Zhang R, Li Z, et al. Clinical and biological significance of circulating tumor cells, circulating tumor DNA, and exosomes as biomarkers in colorectal cancer. Oncotarget. 2017;8(33):55632–55645.
   PubMedGoogle Scholar
• Mohamed Suhaimi N-A, Foong YM, Lee DYS, et al. Non-invasive sensitive detection of KRAS and BRAF mutation in circulating tumor cells of colorectal cancer patients. Mol Oncol. 2015;9(4):850–860.
   PubMed Web of Science ®Google Scholar
• Yang Z-Y, Wu X-Y, Huang Y-F, et al. Promising biomarkers for predicting the outcomes of patients withKRASwild-type metastatic colorectal cancer treated with anti-epidermal growth factor receptor monoclonal antibodies: A systematic review with meta-analysis. Int J Cancer. 2013;133(8):1914–1925.
   PubMed Web of Science ®Google Scholar
• Germano G, Mauri G, Siravegna G, et al. Parallel Evaluation of Circulating Tumor DNA and Circulating Tumor Cells in Metastatic Colorectal Cancer. Clin Colorectal Cancer. 2018;17(1):80–83.
   PubMed Web of Science ®Google Scholar
• Deneve E, Riethdorf S, Ramos J, et al. Capture of Viable Circulating Tumor Cells in the Liver of Colorectal Cancer Patients. Clin Chem. 2013;59(9):1384–1392.
   PubMed Web of Science ®Google Scholar
• Nicolazzo C, Raimondi C, Francescangeli F, et al. EpCAM-Expressing Circulating Tumor Cells in Colorectal Cancer. Int J Biol Markers. 2017;32(4):415–420.
   Web of Science ®Google Scholar
• Tan CRC, Zhou L, El-Deiry WS. Circulating Tumor Cells Versus Circulating Tumor DNA in Colorectal Cancer: Pros and Cons. Curr Colorectal Cancer Rep. 2016;12(3):151–161.
   PubMed Web of Science ®Google Scholar
• Wan Y, Winter M, Delalat B, et al. Nanostructured polystyrene well plates allow unbiased high-throughput characterization of circulating tumor cells. ACS Appl Mater Interfaces. 2014;6(23):20828–20836.
   PubMed Web of Science ®Google Scholar
• Gogoi P, Sepehri S, Zhou Y, et al. Development of an Automated and Sensitive Microfluidic Device for Capturing and Characterizing Circulating Tumor Cells (CTCs) from Clinical Blood Samples. PloS one. 2016;11(1):e0147400.
   PubMed Web of Science ®Google Scholar
• Chen P, Huang YY, Bhave G, et al. Inkjet-Print Micromagnet Array on Glass Slides for Immunomagnetic Enrichment of Circulating Tumor Cells. Ann Biomed Eng. 2016;44(5):1710–1720.
   PubMed Web of Science ®Google Scholar
• Han SI, Han KH. Electrical Detection Method for Circulating Tumor Cells Using Graphene Nanoplates. Anal Chem. 2015;87(20):10585–10592.
   PubMed Web of Science ®Google Scholar
• Matsusaka S, Kozuka M, Takagi H, et al. A novel detection strategy for living circulating tumor cells using 5-aminolevulinic acid. Cancer Lett. 2014;355(1):113–120.
   PubMed Web of Science ®Google Scholar
• Sun W, Jia C, Huang T, et al. High-performance size-based microdevice for the detection of circulating tumor cells from peripheral blood in rectal cancer patients. PloS one. 2013;8(9):e75865.
   PubMed Web of Science ®Google Scholar
• Dharmasiri U, Njoroge SK, Witek MA, et al. High-throughput selection, enumeration, electrokinetic manipulation, and molecular profiling of low-abundance circulating tumor cells using a microfluidic system. Anal Chem. 2011;83(6):2301–2309.
   PubMed Web of Science ®Google Scholar
• Chen JY, Tsai WS, Shao HJ, et al. Sensitive and Specific Biomimetic Lipid Coated Microfluidics to Isolate Viable Circulating Tumor Cells and Microemboli for Cancer Detection. PloS one. 2016;11(3):e0149633.
   PubMed Web of Science ®Google Scholar
• Huang YY, Chen P, Wu CH, et al. Screening and Molecular Analysis of Single Circulating Tumor Cells Using Micromagnet Array. Sci Rep. 2015;5:16047.
   PubMed Web of Science ®Google Scholar
• He R, Zhao L, Liu Y, et al. Biocompatible TiO2 nanoparticle-based cell immunoassay for circulating tumor cells capture and identification from cancer patients. Biomed Microdevices. 2013;15(4):617-626.*
   PubMed Web of Science ®Google Scholar
• Barbazan J, Vieito M, Abalo A, et al. A logistic model for the detection of circulating tumour cells in human metastatic colorectal cancer. J Cell Mol Med. 2012;16(10):2342–2349.
   PubMed Web of Science ®Google Scholar
• Standardisation and improvement of generic pre-analytical tools and procedures for in-vitro diagnostics. Available from: http://www.spidia.eu/
   Google Scholar
• CANCER-ID program. Available from https://www.cancer-id.eu/
   Google Scholar
• The Blood Profiling Atlas in Cancer (BloodPAC). Available from: https://www.bloodpac.org/
   Google Scholar
• Groot Koerkamp B, Rahbari NN, Buchler MW, et al. Circulating tumor cells and prognosis of patients with resectable colorectal liver metastases or widespread metastatic colorectal cancer: a meta-analysis. Ann Surg Oncol. 2013;20(7):2156–2165.
   PubMed Web of Science ®Google Scholar
• Todaro M, Gaggianesi M, Catalano V, et al. CD44v6 Is a Marker of Constitutive and Reprogrammed Cancer Stem Cells Driving Colon Cancer Metastasis. Cell Stem Cell. 2014;14(3):342–356.
   PubMed Web of Science ®Google Scholar
• Buim ME, Fanelli MF, Souza VS, et al. Detection of KRAS mutations in circulating tumor cells from patients with metastatic colorectal cancer. Cancer Biol Ther. 2015;16(9):1289–1295.
   PubMed Web of Science ®Google Scholar
• Nordgard O, Tjensvoll K, Gilje B, et al. Circulating tumour cells and DNA as liquid biopsies in gastrointestinal cancer. Br J Surg. 2018;105(2):e110–e120.
   PubMed Web of Science ®Google Scholar
• Stroun M, Anker P, Lyautey J, et al. Isolation and characterization of DNA from the plasma of cancer patients. Eur J Cancer Clinl Oncol. 1987;23(6):707–712.
   PubMedGoogle Scholar
• Siravegna G, Bardelli A. Genotyping cell-free tumor DNA in the blood to detect residual disease and drug resistance. Genome Biol. 2014;15(8):449.
   PubMed Web of Science ®Google Scholar
• Hodgson DR, Wellings R, Orr MCM, et al. Circulating tumour-derived predictive biomarkers in oncology. Drug Discov Today. 2010; 15 (3–4): 98–101.
   PubMed Web of Science ®Google Scholar
• Jung K, Fleischhacker M, Rabien A. Cell-free DNA in the blood as a solid tumor biomarker—A critical appraisal of the literature. Clin Chim Acta. 2010;411(21–22):1611–1624.
   PubMed Web of Science ®Google Scholar
• Baraniskin A, Van Laethem JL, Wyrwicz L, et al. Clinical relevance of molecular diagnostics in gastrointestinal (GI) cancer: European Society of Digestive Oncology (ESDO) expert discussion and recommendations from the 17th European Society for Medical Oncology (ESMO)/World Congress on Gastrointestinal Cancer, Barcelona. Eur J Cancer. 2017;86:305–317
   PubMed Web of Science ®Google Scholar
• Lecomte T, Berger A, Zinzindohoue F, et al. Detection of free-circulating tumor- associated DNA in plasma of colorectal cancer patients and its association with prognosis. Int J Cancer. 2002;100(5):542–548.
   PubMed Web of Science ®Google Scholar
• Diehl F, Schmidt K, Choti MA, et al. Circulating mutant DNA to assess tumor dynamics. Nat Med. 2008;14(9):985–990.
   PubMed Web of Science ®Google Scholar
• Leary RJ, Sausen M, Kinde I, et al. Detection of chromosomal alterations in the circulation of cancer patients with whole-genome sequencing. Sci Transl Med. 2012;4(162): 162ra154.
   PubMed Web of Science ®Google Scholar
• Bettegowda C, Sausen M, Leary RJ, et al. Detection of circulating tumor DNA in early- and late-stage human malignancies. Sci Transl Med. 2014;6(224): 224ra24.
   Web of Science ®Google Scholar
• Thierry AR, Mouliere F, El Messaoudi S, et al. Clinical validation of the detection of KRAS and BRAF mutations from circulating tumor DNA. Nat Med. 2014;20(4):430–435.
   PubMed Web of Science ®Google Scholar
• Kidess E, Heirich K, Wiggin M, et al. Mutation profiling of tumor DNA from plasma and tumor tissue of colorectal cancer patients with a novel, high-sensitivity multiplexed mutation detection platform. Oncotarget. 2015;6(4):2549–2561.
   PubMedGoogle Scholar
• Damin F, Galbiati S, Soriani N, et al. Analysis of KRAS, NRAS and BRAF mutational profile by combination of in-tube hybridization and universal tag-microarray in tumor tissue and plasma of colorectal cancer patients. PloS one. 2018;13(12):e0207876.
   PubMed Web of Science ®Google Scholar
• Neumann MHD, Bender S, Krahn T, et al. ctDNA and CTCs in Liquid Biopsy – Current Status and Where We Need to Progress. Comput Struct Biotechnol J. 2018;16:190–195.
   PubMed Web of Science ®Google Scholar
• Song Y, Tian T, Shi Y, et al. Enrichment and single-cell analysis of circulating tumor cells. Chem Sci. 2017;8(3):1736–1751.
   PubMed Web of Science ®Google Scholar
• Bedard PL, Hansen AR, Ratain MJ, et al. Tumour heterogeneity in the clinic. Nature. 2013;501(7467):355–3
   PubMed Web of Science ®Google Scholar